Topics

Nordic Nanovector Signs Global Clinical and Commercial Agreement With ITM for the Supply of No-carrier-added Lutetium-177

02:34 EDT 7 Oct 2019 | FinanzNachrichten

OSLO, Norway, Oct. 7, 2019 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that it has signed a long-term global supply agreement with a subsidiary of ITM Isotopen Technologien München...

Original Article: Nordic Nanovector Signs Global Clinical and Commercial Agreement With ITM for the Supply of No-carrier-added Lutetium-177

NEXT ARTICLE

More From BioPortfolio on "Nordic Nanovector Signs Global Clinical and Commercial Agreement With ITM for the Supply of No-carrier-added Lutetium-177"

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...